Cargando…
Neurodevelopment and early pharmacological interventions in Fragile X Syndrome
Fragile X Syndrome (FXS) is a neurodevelopmental disorder and the leading monogenic cause of autism and intellectual disability. For years, several efforts have been made to develop an effective therapeutic approach to phenotypically rescue patients from the disorder, with some even advancing to lat...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433175/ https://www.ncbi.nlm.nih.gov/pubmed/37599992 http://dx.doi.org/10.3389/fnins.2023.1213410 |